IDEAYA Biosciences, Inc. closed a public offering of 7,222,225 shares of common stock and pre-funded warrants to purchase 5,555,576 shares. The offering, led by J.P. Morgan Securities LLC, representatives of the underwriters, and priced at $27.00 per share, generated approximately $323.6 million in net proceeds. IDEAYA Biosciences, Inc. is a biotechnology company focused on developing precision medicine for precision oncology.
